COMMUNIQUÉS West-GlobeNewswire

-
CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes
01/03/2019 -
Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)
01/03/2019 -
European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent
01/03/2019 -
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results
01/03/2019 -
TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Annual Meeting
01/03/2019 -
Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business Update
01/03/2019 -
Expert Dermatologists Present Latest Information at 2019 AAD Annual Meeting
01/03/2019 -
Mithra Reports 2018 Annual Results
01/03/2019 -
Mithra annonce ses résultats annuels 2018
01/03/2019 -
Sport Endurance Enters into Definitive Agreements to Acquire TruPet and Bona Vida
01/03/2019 -
Mersana Therapeutics Announces Pricing of Public Offering of Common Stock
01/03/2019 -
ChromaDex to Present at the 39th Annual Cowen Health Care Conference
01/03/2019 -
Dentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2018 Results
01/03/2019 -
Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2018
01/03/2019 -
Oasmia Pharmaceutical AB (publ)
01/03/2019 -
DBV Technologies to Attend Upcoming Investor Conferences
01/03/2019 -
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
01/03/2019 -
Kiadis Pharma to present at upcoming investor conferences in March 2019
01/03/2019 -
Orphazyme announces Annual Report 2018
01/03/2019
Pages